Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Investing Cash Flow history
Currency unavailable · from the cash flow
No Investing Cash Flow data reported for this period type.
Investing Cash Flow vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $292.04M USD | +591.2% | — | 80.9% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 103.44M SEK | -78.5% | — | 7777.6% |
| LTM Jun 2026 | $82.79M USD | -85.3% | +23.1% | 7.3% | |
| LTM Mar 2026 | $5.5M USD | -48.6% | -67.5% | 4.7% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -63.6% | -22.2% | 44.1% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.